Indometacine Aurobindo

Indometacin, the active ingredient in Indometacine Aurobindo, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral tablet for systemic use. It is employed to reduce pain, swelling and fever in inflammatory musculoskeletal disorders such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute gout and other painful conditions and improve patient mobility throughout the treatment period.

GNH USA supplies Indometacine Aurobindo as a licensed, GDP‑compliant pharmaceutical product to hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and supports reliable international distribution.

Indometacin is an NSAID that acts on inflammatory pathways to relieve symptoms in several rheumatic and musculoskeletal conditions.

Rheumatoid arthritis: reduces joint pain, swelling and stiffness. Osteoarthritis: alleviates chronic joint discomfort and improves function. Ankylosing spondylitis: decreases spinal inflammation and improves mobility. Acute gout: relieves gouty arthritis pain and swelling. Pain and inflammation: provides symptomatic relief in various acute inflammatory conditions.

Indometacin may cause a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo: transient sensations of light‑headedness. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding: potentially life‑threatening hemorrhage. - Renal impairment: acute kidney injury or reduced renal function. - Severe hypersensitivity: Stevens‑Johnson syndrome, toxic epidermal necrolysis or anaphylaxis.

Before prescribing indometacin, clinicians should evaluate patient risk factors and monitor for potential complications. - Assess renal function: check baseline creatinine and adjust use in renal impairment. - Evaluate gastrointestinal risk: consider ulcer prophylaxis in patients with prior GI bleeding. - Review cardiovascular history: NSAIDs may increase blood pressure and thrombotic risk. - Avoid in known hypersensitivity: do not use in patients allergic to indometacin or other NSAIDs. - Store at room temperature: keep in the original container, protect from moisture and heat.

Indometacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Lithium: elevated lithium levels and toxicity. - Other NSAIDs or aspirin: heightened gastrointestinal and renal adverse effects.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in renal perfusion. - ACE inhibitors or ARBs: risk of reduced kidney function and hyperkalaemia.